About
Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for renal diseases and kidney-related disorders. By addressing significant unmet medical needs, Cadrenal utilizes its proprietary drug platforms to advance its promising candidates through rigorous clinical trials. With a robust commitment to scientific excellence and a patient-centric ethos, the company is poised to make a substantial impact in the renal therapeutic landscape, indicating potential for significant growth within the evolving biopharmaceutical sector.
Advanced charting, extended hours trading, and free stock for new accounts.
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.